Cargando…
Improving Medication‐Related Outcomes in Chronic Liver Disease
Patients with chronic liver disease (CLD) are becoming increasingly complex due to the rising prevalence of multimorbidity and polypharmacy. Medications are often essential to manage the underlying liver disease, complications of cirrhosis and portal hypertension, and comorbidities. However, medicat...
Autores principales: | Hayward, Kelly L., Weersink, Rianne A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603526/ https://www.ncbi.nlm.nih.gov/pubmed/33163829 http://dx.doi.org/10.1002/hep4.1612 |
Ejemplares similares
-
Collaboration Is Needed to Translate Pharmacology Data Into Better Health Outcomes in Chronic Liver Disease
por: Weersink, Rianne A., et al.
Publicado: (2021) -
Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patients
por: Weersink, Rianne A., et al.
Publicado: (2020) -
Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis
por: Weersink, Rianne A., et al.
Publicado: (2018) -
Use of Branched-Chain Amino Acids as a Potential Treatment for Improving Nutrition-Related Outcomes in Advanced Chronic Liver Disease
por: Colosimo, Santo, et al.
Publicado: (2023) -
Why zolpidem increases the risk of falls and fractures in patients with cirrhosis
por: Weersink, Rianne Antoinet, et al.
Publicado: (2022)